BPC-157 / TB-500: The Research-Grade Peptide Stack Redefining Recovery Science

In the rapidly evolving landscape of peptide research, few combinations have attracted as much scientific attention as BPC-157 and TB-500. In fact, the BPC-157/TB-500 stack is recognized for its potential across research domains. Together, they represent one of the most studied dual-peptide stacks in preclinical research — and for good reason.



What Is BPC-157?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. With a sequence of 15 amino acids, it has been the subject of extensive preclinical studies examining its role in:

Research suggests BPC-157 may upregulate growth hormone receptors and modulate nitric oxide synthesis, contributing to its observed regenerative properties in laboratory settings.


What Is TB-500?

TB-500 is a synthetic version of Thymosin Beta-4 (Tβ4), a naturally occurring peptide found in virtually all human and animal cells. It plays a critical role in studies involving BPC-157/TB-500, among other research applications.

TB-500’s ability to travel through the bloodstream makes it a subject of interest for systemic, rather than localized, research applications.


Why Researchers Study BPC-157 and TB-500 Together

The BPC-157 / TB-500 combination is frequently explored in research due to their complementary mechanisms of action. Moreover, ongoing investigations into BPC-157/TB-500 aim to reveal additional synergistic benefits for recovery and repair science.

PropertyBPC-157TB-500
Primary ActionLocalized tissue repairSystemic recovery pathways
Key MechanismAngiogenesis, NO modulationActin regulation, cell migration
Research FocusGI, tendon, ligament, neuroMuscle, vascular, anti-inflammatory
Delivery FormatInjectable / Nasal SprayInjectable / Nasal Spray

When studied together, preclinical models suggest a synergistic effect — BPC-157 targeting localized repair while TB-500 supports broader systemic recovery signaling. Consequently, the BPC-157/TB-500 stack holds growing importance in research settings seeking to elucidate the mechanisms of advanced peptide therapies.


NuPepta’s BPC-157 / TB-500 — Research-Grade, USA-Made

At NuPepta, our BPC-157 / TB-500 combination is manufactured to the highest research standards:

Our 10mg / 10mg formulation is available for qualified research applications with no minimum order requirements.


Delivery Innovation: The Protixa ION™ System

Traditional peptide research has relied heavily on injectable formats. NuPepta’s Protixa ION™ System changes that equation. Our nasal spray delivery technology achieves injection-level bioavailability through a proprietary five-mechanism enhancement process — making BPC-157 / TB-500 research more accessible and consistent across laboratory settings.


Important Notice

All NuPepta products, including BPC-157 / TB-500, are strictly intended for research, laboratory, and educational use only. They are not intended for human or veterinary use. Researchers are responsible for compliance with all applicable laws and institutional guidelines.


Explore NuPepta’s full peptide catalog at nupepta.com